Hossein Borghaei, DO, MS, Highlights Findings From the Phase 2 Lung-MAP trial Assessing Ramucirumab and Pembrolizumab in Advanced NSCLC

Press/Media

Period	Aug 29 2022

Media coverage

Title	Hossein Borghaei, DO, MS, Highlights Findings From the Phase 2 Lung-MAP trial Assessing Ramucirumab and Pembrolizumab in Advanced NSCLC
Media name/outlet	Cancernetwork.com
Country/Territory	United States
Date	08/29/22
URL	https://www.cancernetwork.com/view/hossein-borghaei-do-ms-highlights-findings-from-the-phase-2-lung-map-trial-assessing-ramucirumab-and-pembrolizumab-in-advanced-nsclc
Persons	Hossein Borghaei